Induction of Antigen-Specific Tolerance by Oral Administration of Lactococcus lactis Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic Mice
- 15 August 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 183 (4), 2390-2396
- https://doi.org/10.4049/jimmunol.0802891
Abstract
Active delivery of recombinant autoantigens or allergens at the intestinal mucosa by genetically modified Lactococcus lactis (LL) provides a novel therapeutic approach for the induction of tolerance. Celiac disease is associated with either HLA-DQ2- or HLA-DQ8-restricted responses to specific antigenic epitopes of gliadin, and may be treated by induction of Ag-specific tolerance. We investigated whether oral administration of LL-delivered DQ8-specific gliadin epitope induces Ag-specific tolerance. LL was engineered to secrete a deamidated DQ8 gliadin epitope (LL-eDQ8d) and the induction of Ag-specific tolerance was studied in NOD AB° DQ8 transgenic mice. Tolerance was assessed by delayed-type hypersensitivity reaction, cytokine measurements, eDQ8d-specific proliferation, and regulatory T cell analysis. Oral administration of LL-eDQ8d induced suppression of local and systemic DQ8-restricted T cell responses in NOD AB° DQ8 transgenic mice. Treatment resulted in an Ag-specific decrease of the proliferative capacity of inguinal lymph node (ILN) cells and lamina propria cells. Production of IL-10 and TGF-β and a significant induction of Foxp3+ regulatory T cells were associated with the eDQ8d-specific suppression induced by LL-eDQ8d. These data provide support for the development of effective therapeutic approaches for gluten-sensitive disorders using orally administered Ag-secreting LL. Such treatments may be effective even in the setting of established hypersensitivity.Keywords
This publication has 44 references indexed in Scilit:
- Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatmentProceedings of the National Academy of Sciences of the United States of America, 2007
- Celiac disease: pathogenesis of a model immunogenetic diseaseJCI Insight, 2007
- Regulatory T‐cell physiology and application to treat autoimmunityImmunological Reviews, 2006
- Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammationImmunological Reviews, 2006
- Celiac Disease—Sandwiched between Innate and Adaptive ImmunityHuman Immunology, 2006
- Current Issues in the Treatment of Human Diseases by Mucosal ToleranceAnnals of the New York Academy of Sciences, 2004
- Insights into the Mechanism of Oral Tolerance Derived from the Study of Models of Mucosal InflammationAnnals of the New York Academy of Sciences, 2004
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 The Journal of Experimental Medicine, 2003
- Transforming Growth Factor (TGF)-β1–producing Regulatory T Cells Induce Smad-mediated Interleukin 10 Secretion That Facilitates Coordinated Immunoregulatory Activity and Amelioration of TGF-β1–mediated FibrosisThe Journal of Experimental Medicine, 2003
- Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363Gene, 1990